Latest Health News

Lodestar Minerals launches a pro-rata bonus issue of Loyalty Options to existing shareholders, offering potential future capital without immediate dilution. The options are exercisable at $0.01 until August 2029, aiming to reward long-term investors and support company growth.

SRJ Technologies clarifies its financial position and strategic rationale behind a recent capital raise and acquisition of a UAE entity, addressing ASX concerns over its viability and voluntary suspension.

AMP Limited has announced an ordinary dividend of AUD 0.02 per share for the six months ending June 2025, with a 20% franking credit, payable in late September.

RooLife Group has secured a two-year supply agreement with Eternal Asia, granting access to over one million retail outlets across China and potential annual orders worth up to AUD 110 million.

The Calmer Co. International Limited has reported an 81% surge in retail sales through Coles in July, driven by a significant expansion in store presence and strong consumer demand for its natural relaxation products.

Charter Hall Long WALE REIT reports a $118.3 million statutory profit for FY25, reversing last year's heavy loss, while maintaining stable distributions and actively managing debt facilities.

REA Group has reported a robust FY25 with strong revenue and profit growth, underpinned by solid Australian market performance and strategic moves in India. The company also announced a leadership transition amid optimistic FY26 guidance.

Mayne Pharma has firmly rejected a fresh termination notice from Cosette Pharmaceuticals alleging breaches related to FDA disclosure, escalating an ongoing contractual dispute with significant legal implications.

Pinnacle Investment Management announces a fully franked dividend of AUD 0.27 per share for the half-year ending June 2025, offering shareholders a Dividend Reinvestment Plan with currency flexibility.

Nutritional Growth Solutions has completed a $760,000 share placement at a slight discount, aiming to boost inventory and support its retail growth strategy.

Nutritional Growth Solutions revises its Q2 FY25 financials, confirming stable revenue and detailing expanded distribution into CVS and Walmart. The company is actively raising capital to support growth and improve liquidity.

Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.